KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased

Charles River Laboratories International (CRL) Shares Issued (2016 - 2025)

Charles River Laboratories International has reported Shares Issued over the past 16 years, most recently at $711000.0 for Q4 2025.

For Q4 2025, Shares Issued fell 7.42% year-over-year to $711000.0; the TTM value through Dec 2025 reached $714000.0, down 97.01%, while the annual FY2025 figure was $714000.0, 97.01% down from the prior year.
Shares Issued for Q4 2025 was $711000.0 at Charles River Laboratories International, up from $2000.0 in the prior quarter.
Over five years, Shares Issued peaked at $21.5 million in Q1 2024 and troughed at $1000.0 in Q2 2025.
A 5-year average of $6.4 million and a median of $3.9 million in 2023 define the central range for Shares Issued.
Biggest five-year swings in Shares Issued: surged 216.51% in 2022 and later plummeted 99.88% in 2025.
Year by year, Shares Issued stood at $2.3 million in 2021, then surged by 216.51% to $7.4 million in 2022, then decreased by 19.74% to $5.9 million in 2023, then crashed by 87.07% to $768000.0 in 2024, then dropped by 7.42% to $711000.0 in 2025.
Business Quant data shows Shares Issued for CRL at $711000.0 in Q4 2025, $2000.0 in Q3 2025, and $1000.0 in Q2 2025.